SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 45 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $98,000 | +1.0% | 50,804 | 0.0% | 0.02% | +26.3% |
| Q4 2017 | $97,000 | +59.0% | 50,804 | 0.0% | 0.02% | +90.0% |
| Q3 2017 | $61,000 | -4.7% | 50,804 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $64,000 | +4.9% | 50,804 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $61,000 | -39.0% | 50,804 | 0.0% | 0.01% | -41.2% |
| Q4 2016 | $100,000 | -44.1% | 50,804 | 0.0% | 0.02% | -39.3% |
| Q3 2016 | $179,000 | -1.6% | 50,804 | 0.0% | 0.03% | -33.3% |
| Q2 2016 | $182,000 | -25.7% | 50,804 | 0.0% | 0.04% | -34.4% |
| Q1 2016 | $245,000 | -79.5% | 50,804 | -75.0% | 0.06% | -69.2% |
| Q4 2015 | $1,198,000 | -50.3% | 203,438 | -50.0% | 0.21% | -15.8% |
| Q3 2015 | $2,412,000 | -15.6% | 406,876 | +93.8% | 0.25% | -28.8% |
| Q2 2015 | $2,859,000 | +6.2% | 210,000 | 0.0% | 0.35% | +1.5% |
| Q1 2015 | $2,692,000 | -39.2% | 210,000 | -51.3% | 0.34% | -41.1% |
| Q4 2014 | $4,428,000 | – | 431,582 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 431,582 | $4,428,000 | 0.58% |
| AWM Investment Company, Inc. | 234,965 | $2,411,000 | 0.33% |
| DAFNA Capital Management LLC | 39,800 | $408,000 | 0.32% |
| AYM CAPITAL, LLC | 15,193 | $156,000 | 0.12% |
| CARL DOMINO INC | 20,350 | $209,000 | 0.11% |
| JW Asset Management, LLC | 8,500 | $87,000 | 0.06% |
| NumerixS Investment Technologies Inc | 13,800 | $142,000 | 0.05% |
| FIDUCIARY TRUST INTERNATIONAL LLC | 14,100 | $145,000 | 0.04% |
| Cubist Systematic Strategies, LLC | 15,711 | $161,000 | 0.01% |
| REGIONS FINANCIAL CORP | 32,000 | $328,000 | 0.00% |